Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-06-019278
Filing Date
2006-05-10
Accepted
2006-05-10 16:41:46
Documents
2
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 v042399_10k-a.htm 10-K/A 37393
2 v042399_ex10-21.htm EX-10.21 289576
  Complete submission text file 0001144204-06-019278.txt   328280
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)

EIN.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30929 | Film No.: 06826781
SIC: 2834 Pharmaceutical Preparations